Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Astrazeneca Plc ADR (AZN)

Astrazeneca Plc ADR (AZN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 203,407,856
  • Shares Outstanding, K 3,098,840
  • Annual Sales, $ 37,417 M
  • Annual Income, $ 112,000 K
  • 60-Month Beta 0.45
  • Price/Sales 5.34
  • Price/Cash Flow 14.45
  • Price/Book 5.18
Trade AZN with:

Options Overview Details

View History
  • Implied Volatility 29.38% ( +2.32%)
  • Historical Volatility 29.78%
  • IV Percentile 82%
  • IV Rank 64.83%
  • IV High 35.62% on 11/08/21
  • IV Low 17.88% on 08/04/21
  • Put/Call Vol Ratio 0.84
  • Today's Volume 4,109
  • Volume Avg (30-Day) 3,705
  • Put/Call OI Ratio 1.09
  • Today's Open Interest 159,607
  • Open Int (30-Day) 151,452

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 0.78
  • Number of Estimates 3
  • High Estimate 0.80
  • Low Estimate 0.75
  • Prior Year 0.45
  • Growth Rate Est. (year over year) +73.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
60.34 +4.94%
on 05/12/22
69.19 -8.48%
on 04/20/22
-5.29 (-7.71%)
since 04/18/22
3-Month
56.36 +12.35%
on 03/08/22
71.70 -11.69%
on 04/08/22
+3.46 (+5.78%)
since 02/18/22
52-Week
53.63 +18.07%
on 12/07/21
71.70 -11.69%
on 04/08/22
+7.33 (+13.09%)
since 05/18/21

Most Recent Stories

More News
AstraZeneca (AZN) Inks Deal to Develop COVID-19 Antibodies

AstraZeneca (AZN) partners with a U.K.-based biotech company to develop monoclonal antibodies targeting the COVID-causing virus.

AZN : 63.32 (-3.53%)
GSK : 43.63 (-2.42%)
LLY : 295.19 (-2.06%)
VIR : 22.71 (-1.65%)
Valneva (VALN) Down as EU Considers Ending COVID-Vaccine Deal

Per the agreement with the European Commission, Valneva (VALN) has 30 days from May 13, 2022 to win a marketing authorization in the EU for its COVID vaccine or offer an acceptable remediation plan.

AZN : 63.32 (-3.53%)
PFE : 50.40 (-1.83%)
ALKS : 28.87 (-2.76%)
VALN : 21.00 (-3.09%)
PT027, a Novel Fixed-Dose Combination of Albuterol and Budesonide, Used as an As-Needed Rescue Medicine, Significantly Reduced the Risk of a Severe Exacerbation Compared to Albuterol by 27% in Patients With Asthma

Full results from the positive MANDALA Phase III trial showed that PT027 (albuterol/budesonide) at two different strengths of budesonide, an inhaled corticosteroid (ICS), used as an as-needed rescue medicine,...

AZN : 63.32 (-3.53%)
Diversify Outside the U.S. With This ETF

Many of the largest, most profitable companies are located in the U.S. And it’s likely that investors ...

VXUS : 53.95 (-2.30%)
TSM : 90.53 (-2.99%)
AZN : 63.32 (-3.53%)
RHHBY : 40.3400 (-0.07%)
Why GSK May Have Bet Too Big on a Pandemic Pipeline

Its late-stage pipeline is heavily weighted toward pandemic treatments.

GSK : 43.63 (-2.42%)
SNY : 52.39 (-0.96%)
PFE : 50.40 (-1.83%)
MRNA : 137.71 (-3.21%)
AZN : 63.32 (-3.53%)
NVAX : 52.11 (+0.31%)
3 Top Biotech Stocks to Buy Right Now

These three pharma stocks each pay market-beating dividends to shareholders.

SNY : 52.39 (-0.96%)
PFE : 50.40 (-1.83%)
AZN : 63.32 (-3.53%)
Ironwood (IRWD) Q1 Earnings Miss, Linzess Growth Continues

Ironwood (IRWD) witnesses strong year-over-year sales growth on continued demand for Linzess. Its first-quarter earnings miss estimates. The company maintains revenue guidance for 2022. Stock declines....

AZN : 63.32 (-3.53%)
IRWD : 11.41 (-2.06%)
ABBV : 152.43 (-1.52%)
XNCR : 22.55 (-9.11%)
Apellis (APLS) Hit By Wider-Than-Expected Q1 Loss, Revenues Top

Apellis' (APLS) earnings missed estimates in the first quarter of 2022, while revenues surpassed expectations.

AZN : 63.32 (-3.53%)
VRTX : 252.35 (-3.62%)
APLS : 43.52 (+3.23%)
APLT : 1.5700 (-7.65%)
3 Nasdaq 100 Stocks to Buy Hand Over Fist in May

These fast-paced stocks are plain-as-day bargains.

BIDU : 118.86 (-3.71%)
AZN : 63.32 (-3.53%)
AVGO : 570.57 (-6.18%)
Ionis (IONS) Q1 Earnings & Sales Beat Estimates, Stock Rises

Ionis (IONS) incurs a narrower-than-expected loss in Q1. Its sales also come ahead of estimates. Stock moves up in response to the results.

AZN : 63.32 (-3.53%)
NVS : 87.68 (-0.27%)
BIIB : 195.71 (-3.54%)
IONS : 38.39 (-0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition...

See More

Key Turning Points

3rd Resistance Point 65.51
2nd Resistance Point 65.02
1st Resistance Point 64.17
Last Price 63.32
1st Support Level 62.84
2nd Support Level 62.35
3rd Support Level 61.50

See More

52-Week High 71.70
Fibonacci 61.8% 64.80
Last Price 63.32
Fibonacci 50% 62.67
Fibonacci 38.2% 60.53
52-Week Low 53.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar